Renalytix Statistics
Total Valuation
Renalytix has a market cap or net worth of 19.73 million. The enterprise value is 23.69 million.
| Market Cap | 19.73M |
| Enterprise Value | 23.69M |
Important Dates
The last earnings date was Thursday, October 10, 2024.
| Earnings Date | Oct 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | +31.59% |
| Shares Change (QoQ) | +41.48% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 155.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.71 |
| EV / Sales | 10.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.79 |
Financial Position
The company has a current ratio of 0.53
| Current Ratio | 0.53 |
| Quick Ratio | 0.47 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.28 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -93.54% |
| Return on Capital (ROIC) | -182.66% |
| Revenue Per Employee | 22,441 |
| Profits Per Employee | -328,000 |
| Employee Count | 102 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.17% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -86.17% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.50 |
| Relative Strength Index (RSI) | 31.61 |
| Average Volume (20 Days) | 357,825 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Renalytix had revenue of 2.29 million and -33.46 million in losses. Loss per share was -0.31.
| Revenue | 2.29M |
| Gross Profit | 156,000 |
| Operating Income | -28.89M |
| Pretax Income | -33.45M |
| Net Income | -33.46M |
| EBITDA | -28.62M |
| EBIT | -28.89M |
| Loss Per Share | -0.31 |
Balance Sheet
The company has 4.68 million in cash and 8.54 million in debt, giving a net cash position of -3.86 million.
| Cash & Cash Equivalents | 4.68M |
| Total Debt | 8.54M |
| Net Cash | -3.86M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -7.85M |
| Book Value Per Share | -0.05 |
| Working Capital | -5.38M |
Cash Flow
In the last 12 months, operating cash flow was -30.11 million and capital expenditures -4,000, giving a free cash flow of -30.12 million.
| Operating Cash Flow | -30.11M |
| Capital Expenditures | -4,000 |
| Free Cash Flow | -30.12M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 6.82% |
| Operating Margin | -1,261.90% |
| Pretax Margin | -1,461.42% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,315.64% |
Dividends & Yields
Renalytix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.59% |
| Shareholder Yield | -31.59% |
| Earnings Yield | -206.67% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Renalytix has an Altman Z-Score of -47.39. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -47.39 |
| Piotroski F-Score | n/a |